11/14/2024
4:46 PM | Ascendis Pharma A/S (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
1:57 PM | Ascendis Pharma A/S (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
11/14/2024
8:31 AM | Ascendis Pharma A/S (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
11/13/2024
3:02 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/12/2024
8:51 AM | Artisan Partners Limited Partnership (Filed by)
Ascendis Pharma A/S (Subject)
| Form SC 13G/A | |
11/08/2024
9:34 AM | Ascendis Pharma A/S (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/04/2024
6:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
09/30/2024
7:35 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/27/2024
3:59 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2024
4:20 PM | Ascendis Pharma A/S (Filer)
| Form 424B5 | |
09/18/2024
3:01 PM | Ascendis Pharma A/S (Filer)
| Form F-3ASR | |
09/16/2024
6:28 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024
6:32 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2024
3:01 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024
4:10 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024
4:11 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024
4:14 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/12/2024
6:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/28/2024
5:07 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2024
3:26 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2024
3:08 PM | Ascendis Pharma A/S (Filer)
| Form SD
Specialized Disclosure Report | |
05/14/2024
1:37 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2024
8:16 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024
10:31 AM | Ascendis Pharma A/S (Subject)
Bodenhoff Mads (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
8:39 PM | Ascendis Pharma A/S (Subject)
Fairey William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
8:47 AM | Ascendis Pharma A/S (Subject)
Cha Albert (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
7:04 AM | Ascendis Pharma A/S (Subject)
SPROGOE KENNETT (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
7:14 AM | Ascendis Pharma A/S (Subject)
Morrison Lisa (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
6:52 AM | Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
6:37 AM | Ascendis Pharma A/S (Subject)
JENSEN FLEMMING STEEN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
1:54 PM | Ascendis Pharma A/S (Subject)
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
2:07 PM | Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
2:17 PM | Ascendis Pharma A/S (Subject)
RASMUSSEN PETER (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
1:36 PM | Ascendis Pharma A/S (Subject)
SMITH SCOTT THOMAS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
1:24 PM | Ascendis Pharma A/S (Subject)
SINGEL STINA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
10:00 AM | Ascendis Pharma A/S (Subject)
HOLTUG LARS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
4:13 PM | Ascendis Pharma A/S (Subject)
Morrison Lisa (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
3:21 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2024
5:17 PM | Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
4:45 PM | Ascendis Pharma A/S (Subject)
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
2:17 PM | Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad) Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code…
And since then…
"In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics… Get Your Free Gold Guide |
02/16/2024
4:14 PM | Ascendis Pharma A/S (Subject)
Volck Birgitte (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
4:15 PM | Ascendis Pharma A/S (Subject)
JENSEN FLEMMING STEEN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
4:16 PM | Ascendis Pharma A/S (Subject)
SMITH SCOTT THOMAS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
10:40 AM | Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
8:17 AM | Ascendis Pharma A/S (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
02/13/2024
10:57 AM | Ascendis Pharma A/S (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
02/12/2024
5:12 AM | Artisan Partners Limited Partnership (Filed by)
Ascendis Pharma A/S (Subject)
| Form SC 13G/A | |
02/09/2024
1:17 PM | Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
7:35 AM | Ascendis Pharma A/S (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/07/2024
3:15 PM | Ascendis Pharma A/S (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
02/02/2024
12:18 PM | Ascendis Pharma A/S (Subject)
WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by)
| Form SC 13G/A | |
01/29/2024
7:36 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024
5:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024
5:08 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/02/2024
5:08 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2023
7:30 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2023
7:32 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/07/2023
1:53 PM | Ascendis Pharma A/S (Subject)
Volck Birgitte (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/05/2023
3:20 PM | Ascendis Pharma A/S (Subject)
RASMUSSEN PETER (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023
5:04 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Free ASND Stock Alerts